Skip to main content
. 2016 Jun 28;22(24):5459–5466. doi: 10.3748/wjg.v22.i24.5459

Table 1.

A comparison of clinic-pathological data between type-B and type-C hepatocellular carcinoma

Type B (n = 97) Type C (n = 81) P value
Age (yr) 56.1 ± 11.9 66.7 ± 9.8 < 0.0001
Sex (M:F) 71.1%:28.9% 60.5%:39.5% 0.18
AST (IU/L) 82.2 ± 98.6 81.8 ± 44.1 0.18
ALT (IU/L) 67.7 ± 70.9 83.2 ± 56.9 0.11
T.Bil (mg/dL) 1.2 ± 1.1 1.0 ± 0.6 0.36
Alb (g/dL) 4.0 ± 0.6 3.9 ± 0.5 0.22
Plt (/mm3) 13.9 ± 8.1 10.8 ± 5.5 < 0.005
Histology
F1:2:3:4 2:20:3:32 1:6:8:21 < 0.005
A1:2:3 17:25:12 1:14:17 < 0.005
Clinical stage (I:II:III:IV) 12:29:25:31 15:32:29:5 < 0.0005